Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New pathway discovered at Stanford provides insight into heart disease

13.11.2003


A new signaling pathway appears to play a critical role in the development of heart disease, according to researchers at Stanford University School of Medicine. Now that this marker of cardiac dysfunction, known as the APJ-apelin pathway, has been identified, it could lead to better diagnosis of heart problems, perhaps even allowing doctors to intervene in heart disease by blocking or boosting levels of critical proteins.

"The thing that’s clear is that apelin is increased in heart failure," said Euan Ashley, MD, PhD, a clinical fellow in cardiovascular medicine and one of the lead authors of the study, which is being presented at a Nov. 12 poster session at the annual American Heart Association meeting in Orlando.

"The idea of a blood test to help make a diagnosis of heart disease is very appealing," Ashley said. "But my bigger hope is for therapeutic potential, and given what we know about apelin levels changing a lot during heart failure, either blocking or enhancing this system may provide a treatment for heart failure."



The apelin-APJ signaling pathway’s role in cardiac health was discovered through straightforward techniques combined in such a way that made a previously unnoticed connection apparent. Researchers united Stanford’s long experience with cardiac-assist devices with the ability of microarrays to scan for the activity of thousands of genes at once. In the study, researchers looked at two different heart tissue samples from each patient. One sample came from patients suffering end-stage heart disease before any type of surgical intervention, and the second sample was taken after the same patients’ hearts had recovered with the help of artificial pumps known as left-ventricular assist devices, or LVADs.

The patients in this study relied upon LVADs for up to a year to pump their blood as they waited for an appropriate donor heart to become available for transplant. When the device was implanted, a small section of heart tissue had to be removed, which provided the "before" sample for the study. Once a donor heart arrived, the patient’s old heart became the "after" sample.

"By comparing the two states, the genes we are seeing show the differences between the patients at their worst and when their hearts have had a chance to recover for a bit," said Mary Chen, life science research assistant in cardiovascular medicine and the other lead author of the study. In other words, the things that get worse during heart failure improve with the aid of an LVAD.

Genes that change during the recovery process could provide valuable insight into the progression of heart disease because heart tissue after LVAD use approximates the patient’s healthy heart. The researchers screened matched samples from 11 male patients before and after their heart transplants using microarrays to test for the activity of more than 12,000 genes. Among the genes that changed greatly between the two states was one called BNP, already known to be the first marker of heart disease to date. While this provided some confirmation of their technique, far more intriguing was the discovery of a new pathway.

"Right at the top of our list was a gene that nobody had paid any attention to," said Ashley. "That was our first light bulb." He explained that the gene they found to be most active in the recovering heart was related to angiotensin - shown 20 years ago to be important in heart failure, leading to the class of drugs known as ACE inhibitors. The gene they found produces a receptor called APJ. The protein that combines with this receptor is apelin, which had been shown recently to be perhaps the most potent stimulator of heart contractions ever discovered. Nobody had connected apelin and APJ to cardiac failure until now, the researchers said.

To provide further evidence that apelin played a role in heart disease, the Stanford team detected the protein in human blood. Once they determined what a normal range was, they looked at patients with various stages of heart disease and found that the level of apelin in a person’s blood reflected the condition of their heart determined by standard methods. They further showed that apelin is located in the lining of the blood vessels, but it signals to the receptor APJ in the heart.



Other Stanford researchers who contributed to this presentation are Alicia Deng, life science research assistant in cardiovascular medicine; Philip Tsao, PhD, assistant professor of research in cardiovascular medicine; and Thomas Quertermous, MD, the William G. Irwin Professor in Cardiovascular Medicine. This work was supported by the Donald W. Reynolds Cardiovascular Clinical Research Center at Stanford.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.

PRINT MEDIA CONTACT: Mitzi Baker at 650-725-2106 (mitzibaker@stanford.edu)
BROADCAST MEDIA CONTACT: M.A. Malone at 650-723-6912 (mamalone@stanford.edu)

Mitzi Baker | EurekAlert!
Further information:
http://med-www.stanford.edu/MedCenter/MedSchool/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>